[HTML][HTML] Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - Angiogenesis, 2022 - Springer
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
[HTML][HTML] Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - Angiogenesis, 2022 - ncbi.nlm.nih.gov
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial.
Y Shimizu, K Kondo, R Hayashida, KI Sasaki… - Angiogenesis, 2022 - europepmc.org
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
[引用][C] Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - Angiogenesis, 2022 - cir.nii.ac.jp
Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived
regenerative cells: TACT-ADRC multicenter trial | CiNii Research CiNii 国立情報学研究所 学術 …
regenerative cells: TACT-ADRC multicenter trial | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF][PDF] Therapeutic angiogenesis for patients with no‑option critical limb ischemia by adipose‑derived regenerative cells: TACT‑ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - Angiogenesis, 2022 - gc-science.co.jp
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - …, 2022 - search.proquest.com
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
[PDF][PDF] Therapeutic angiogenesis for patients with no‑option critical limb ischemia by adipose‑derived regenerative cells: TACT‑ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida, K Sasaki… - 2022 - academia.edu
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …
Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial
Y Shimizu, K Kondo, R Hayashida… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Patients with critical limb ischemia (CLI) still have a high rate of lower limb
amputation, which is associated with not only a decrease in quality of life but also poor life …
amputation, which is associated with not only a decrease in quality of life but also poor life …